1. Home
  2. LRFC vs IVVD Comparison

LRFC vs IVVD Comparison

Compare LRFC & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRFC
  • IVVD
  • Stock Information
  • Founded
  • LRFC 2013
  • IVVD 2020
  • Country
  • LRFC United States
  • IVVD United States
  • Employees
  • LRFC N/A
  • IVVD N/A
  • Industry
  • LRFC Finance: Consumer Services
  • IVVD Biotechnology: Pharmaceutical Preparations
  • Sector
  • LRFC Finance
  • IVVD Health Care
  • Exchange
  • LRFC Nasdaq
  • IVVD Nasdaq
  • Market Cap
  • LRFC 66.5M
  • IVVD 66.6M
  • IPO Year
  • LRFC 2013
  • IVVD 2021
  • Fundamental
  • Price
  • LRFC $24.78
  • IVVD $1.77
  • Analyst Decision
  • LRFC
  • IVVD Strong Buy
  • Analyst Count
  • LRFC 0
  • IVVD 4
  • Target Price
  • LRFC N/A
  • IVVD $7.89
  • AVG Volume (30 Days)
  • LRFC 9.7K
  • IVVD 40.7M
  • Earning Date
  • LRFC 03-13-2025
  • IVVD 03-27-2025
  • Dividend Yield
  • LRFC 5.42%
  • IVVD N/A
  • EPS Growth
  • LRFC N/A
  • IVVD N/A
  • EPS
  • LRFC N/A
  • IVVD N/A
  • Revenue
  • LRFC $19,936,000.00
  • IVVD $11,564,000.00
  • Revenue This Year
  • LRFC $3.63
  • IVVD N/A
  • Revenue Next Year
  • LRFC N/A
  • IVVD $599.08
  • P/E Ratio
  • LRFC N/A
  • IVVD N/A
  • Revenue Growth
  • LRFC N/A
  • IVVD N/A
  • 52 Week Low
  • LRFC $20.65
  • IVVD $0.36
  • 52 Week High
  • LRFC $26.00
  • IVVD $4.74
  • Technical
  • Relative Strength Index (RSI)
  • LRFC 52.18
  • IVVD 62.64
  • Support Level
  • LRFC $24.22
  • IVVD $1.20
  • Resistance Level
  • LRFC $25.00
  • IVVD $1.62
  • Average True Range (ATR)
  • LRFC 0.34
  • IVVD 0.51
  • MACD
  • LRFC 0.01
  • IVVD -0.01
  • Stochastic Oscillator
  • LRFC 71.79
  • IVVD 57.90

About LRFC Logan Ridge Finance Corporation

Logan Ridge Finance Corp an externally managed non-diversified closed-end management investment company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company offers customized financing to business owners, management teams, and financial sponsors for change of ownership transactions, recapitalizations, strategic acquisitions, business expansion, and other growth initiatives.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: